Benjamin F. Edwards & Company’s Axogen AXGN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1K	Hold	200	–	–	﹤0.01%	2078
2024 Q1	$2K	Hold	200	–	–	﹤0.01%	2003
2023 Q4	$1K	Hold	200	–	–	﹤0.01%	2023
2023 Q3	$1K	Sell	200 -5,000	-96%	-$34.6K	﹤0.01%	1701
2023 Q2	$47K	Hold	5,200	–	–	﹤0.01%	1106
2023 Q1	$49K	Hold	5,200	–	–	﹤0.01%	1099
2022 Q4	$52K	Hold	5,200	–	–	﹤0.01%	1066
2022 Q3	$62K	Hold	5,200	–	–	﹤0.01%	995
2022 Q2	$43K	Hold	5,200	–	–	﹤0.01%	1076
2022 Q1	$41K	Buy	5,200 +200	+4%	+$1.73K	﹤0.01%	1074
2021 Q4	$47K	Hold	5,000	–	–	﹤0.01%	1064
2021 Q3	$79K	Hold	5,000	–	–	﹤0.01%	909
2021 Q2	$108K	Hold	5,000	–	–	0.01%	825
2021 Q1	$101K	Buy	+5,000	New	+$98.8K	0.01%	831

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Benjamin F. Edwards & Company's AXGN Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Axogen (AXGN) position steady in Q2 2024 at 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

Benjamin F. Edwards & Company first reported a position in AXGN in Q1 2021 and has held it in 14 quarters since. The position peaked at $108K in Q2 2021. 125 funds tracked by Wall St. Rank hold AXGN as of Q2 2024.

Benjamin F. Edwards & Company held 200 shares of Axogen worth $1K as of Q2 2024.
Benjamin F. Edwards & Company left its Axogen share count unchanged in Q2 2024.
Axogen made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2078 holding.
Benjamin F. Edwards & Company first reported a position in Axogen in Q1 2021 and has held it in 14 quarters since.
Benjamin F. Edwards & Company's Axogen position peaked at $108K in Q2 2021.
125 funds tracked by Wall St. Rank held Axogen as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.